Rankings
▼
Calendar
AMRX FY 2022 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
FY 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.2B
+5.7% YoY
Gross Profit
$791M
35.8% margin
Operating Income
-$95M
-4.3% margin
Net Income
-$130M
-5.9% margin
EPS (Diluted)
$-0.86
Cash Flow
Operating Cash Flow
$65M
Free Cash Flow
-$25M
Stock-Based Comp.
$32M
Balance Sheet
Total Assets
$3.8B
Total Liabilities
$3.6B
Stockholders' Equity
$298M
Cash & Equivalents
$26M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.2B
$2.1B
+5.7%
Gross Profit
$791M
$769M
+2.9%
Operating Income
-$95M
$153M
-162.2%
Net Income
-$130M
$11M
-1323.5%
← Q4 2021
All Quarters
Q1 2022 →